medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2006, Number 02

<< Back Next >>

Ginecol Obstet Mex 2006; 74 (02)

Natural history of breast cancer

Novoa VA, Pliego AM, Malagón MB, Bustillos CR

Language: Spanish
References: 35
Page: 115-120
PDF size: 90.58 Kb.


ABSTRACT

Breast women cancer is a disease with a lot of paradigms; then, it is a big problem of health. It is important to know its nature history, because breast cancer has a multifactor onset; therefore, we have to understand its behavior, since its risks factors, until patient’s death by metastatic disease in the host. In this work we made a bibliography, analytic review that brings up concepts related since theirs sources, evolution, preclinical horizon, and clinical symptoms to the dead of host.


REFERENCES

  1. National Center for Health Statistics: Health, United States, 1987. Department of Health and Human Services Publication (PHS). Washington DC, Government Printing Office, 1988.

  2. Departamento de Epidemiología de la Secretaría de Salud, México, 1993.

  3. Paredes LA, Argüero BJ. Sensibilidad, especificidad y valor predictivo del examen físico y de la mamografía en el diagnóstico del cáncer de mama. Rev Inst Nal Cancerol (Méx) 1995;54:41(2):89-92.

  4. Simpson JF, Gray R, Dressler LG, et al. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol 2000;18(10):2059-69.

  5. Cattoretti S, Rilke F, Andreola S, Dámto L, Delia D. p53 expression in breast cancer. Int J Cancer 1988;41:178-83.

  6. Rosen PP, Groshen S, Kinne DW. Prognosis in T2N0M0 stage I breast carcinoma: A 20-year follow-up study. J Clin Oncol 1991;9(9):1650-61.

  7. Kinne DW, Hakes TB. Male breast cancer. En: Harris JR, Hellman S, Henderson IC, Kinne DW, editors. Breast disease. 2nd ed. Philadelphia: JB Lippincott, 1991;pp:782-90.

  8. Henson DE, Tarone RE. On the possible role of involution in the natural history of breast cancer. Cancer 1993;71(6):2154-56.

  9. MacMahon B, Cole P, Brown J. Etiology of human breast cancer. J Natl Cancer Inst 1973;50:21-42.

  10. Mirra AP, Cole P, MacMahon B. Breast cancer in an area of high parity. Sao Paulo, Brazil. Cancer Res 1971;31:77-83.

  11. Vogel PM, Georgiade NG, Fetter BF, et al. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 1981;104:23-34.

  12. Romieu I, Berlin JA, Colditz G. Oral contraceptives and breast cancer. Review and metaanalisys. Cancer 1990;66:2253-63.

  13. Ford lG, Dunn BK in Proceedings of the 11th NCI-EORT-AACR SYMPOSIUM: SERMS in action: Ongoing research in breast cancer prevention. AACR 2000;6:1078.

  14. Smart Ch, Hartman WH, Behars OH, Garfinkel L. Insights into breast cancer screening of young women. Cancer 1993;72(4):1449-56.

  15. Claus EB, Risch N, Thompson WD. Autosomal inheritance of early-onset breast cancer: implications for risk prediction. Cancer 1994;73(3):643-51.

  16. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examinated annually. J Natl Cancer Inst 1989;81(24):1879-86.

  17. Blackwood MA, Weber BL. BRCA1 and BRCA2: From molecular genetics to clinical medicine. J Clin Oncol 1998;16(5):1969-77.

  18. Frank TS, Manley SA, Olopade OI, et al. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 1998;16(7):2417-25.

  19. Ruiz-Flores P, Calderón-Garcidueñas AL, Barrera-Saldaña HA. Genética del cáncer de mama, BRCA1, BRCA2: Los principales genes de predisposición a la enfermedad. Rev Invest Clin 2001;53(1):46-64.

  20. Yoshimoto M, Sakamoto G, Ohashi Y. Time dependency of the influence of prognostic factors on relapse in breast cancer. Cancer 1193;72(10):2993-3001.

  21. Adair R, Berg J, Joubert L, et al. Long-term follow-up of breast cancer patients: The 30-year report. Cancer 1974;33:1145-50.

  22. Albano WA, Hanf CD, Organ Jr CH. Natural history of Iymph node-negative breast cancer. Surgery 1979;86: 574-77.

  23. Fisher E. The impact of pathology on the biologic, diagnostic, prognostic and therapeutic considerations in breast cancer. Surg Clin North Am 1984;64(6):1073-93.

  24. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.

  25. Broders AC. Squamous cell epitehlioma of the skin. Ann Surg 1921;73:141-60.

  26. Greenhouegh RB. Varying degrees of malignancy in cancer of the breast. J Cancer Res 1925;9:452-63.

  27. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957;11(3):359-77.

  28. Black MM, Barclay TH, Hankey BF. Prognosis in breast cancer utilizing histology characteristics of the primary tumor. Cancer 1975;36:2048-55.

  29. Robbins S. Patología estructural y funcional. México, Interamericana, 1988;pp:1218-48.

  30. Ackerman LV. Surgical pathology. 7th ed. St Louis: Mosby, 1989;pp:1218-45.

  31. Cooperman AM, Herman R. Breast cancer: An Overview. Symposium on breast cancer. Surg Clin North Am 1984;64(6):1031-8.

  32. Rosen PP, Senie RT, Farr RH, Schottenfeld D, Ashikari R. Epidemiology of breast carcinoma: Age, menstrual status, androxenous hormone usage in patients with lobular carcinoma in situ. Surgery 1981;194:585-91.

  33. Martell GRJ, Miranda HH, Serrano MJA, Sandoval GF. Cancerol 1994;40(2):71-75.

  34. López-Graniel C, Meneses GA. Angiogénesis. Cancerol 2000;46(2):78-80.

  35. Alfaro ME, García CC, Dueñas GA. Métodos de detección de la apoptosis, aplicaciones y limitaciones. Cancer 2000;46(4):275-80.




2020     |     www.medigraphic.com